Literature DB >> 4742467

Immunological studies on the mechanism of gold hypersensitivity reactions.

P Davis, A Ezeoke, J Munro, J R Hobbs, G R Hughes.   

Abstract

Immunological studies were performed on 12 patients with rheumatoid arthritis who developed reactions to gold. IgE levels were found to be raised in 10 of 11 patients tested at the time of the gold reaction, returning to normal on stopping therapy. Two of 12 patients with gold reactions had positive in-vitro lymphocyte transformation responses to gold.It is suggested that dermatological side effects in particular are mediated by a type I hypersensitivity response.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4742467      PMCID: PMC1587048          DOI: 10.1136/bmj.3.5882.676

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Lymphocyte transformation in drug hypersensitivity.

Authors:  I Sarkany
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

3.  Lymphocyte cultures in drug hypersensitivity.

Authors:  T L Vischer
Journal:  Lancet       Date:  1966-08-27       Impact factor: 79.321

4.  Severe hypersensitivity reaction to gold. Positive lymphocyte transformation test.

Authors:  R A Walzer; R Feinstein; L Shapiro; J Einbinder
Journal:  Arch Dermatol       Date:  1972-08

5.  A research standard for human serum immunoglobulins IgG, IgA and IgM.

Authors:  D S Rowe; S G Anderson; B Grab
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

6.  Serum IgE elevation with tropical eosinophilia.

Authors:  A Ezeoke; A B Perera; J R Hobbs
Journal:  Clin Allergy       Date:  1973-03

7.  [Lymphocyte transformation and immunoglobulins during gold therapy].

Authors:  H W Baenkler; F Scheiffarth
Journal:  Z Rheumaforsch       Date:  1971 Jul-Aug

8.  The lymphocyte transformation test and gold hypersensitivity.

Authors:  E J Denman; A M Denman
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

9.  Effect of a gold salt on the immune response.

Authors:  R H Persellin; E V Hess; M Ziff
Journal:  Arthritis Rheum       Date:  1967-04
  9 in total
  11 in total

1.  Immunotoxicity of immunotherapeutic agents.

Authors:  A G Johnson; J Regal
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Immunofluorescence of the skin in gold rashes - with particular reference to IgE.

Authors:  J M Iveson; D G Scott; W D Perera; W J Cunliffe; V Wright
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

3.  Serum IgE concentrations in rheumatoid arthritis: lack of correlation with gold toxicity.

Authors:  D M Grennan; D G Palmer
Journal:  Br Med J       Date:  1979-12-08

4.  Editorial: Gold therapy in 1975.

Authors: 
Journal:  Br Med J       Date:  1975-04-26

5.  Diffuse lung changes associated with gold therapy.

Authors:  S M Sepuya; S Grzybowski; J D Burton; J G Clement
Journal:  Can Med Assoc J       Date:  1978-04-08       Impact factor: 8.262

Review 6.  Mechanisms of action of gold.

Authors:  J H Leibfarth; R H Persellin
Journal:  Agents Actions       Date:  1981-11

7.  Immunosuppressant effect of gold on IgG subclasses and IgE; evidence for sparing of Th2 responses.

Authors:  P D Kiely; M R Helbert; J Miles; D B Oliveira
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

8.  Gold-induced thrombocytopenia: detection of anti-platelet antibody.

Authors:  R D Armstrong; A Faith; G S Panayi; J R Batchelor
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

9.  Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.

Authors:  S M Wilkinson; A G Smith; M J Davis; D Mattey; P T Dawes
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

Review 10.  Drug-induced anaemias.

Authors:  R H Girdwood
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.